Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $21.39 $26.48 Wednesday, 8th May 2024 ARWR stock ended at $25.22. This is 0.88% more than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 3.99% from a day low at $24.30 to a day high of $25.27.
90 days $21.39 $36.72
52 weeks $20.67 $41.28

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
Aug 08, 2016 $6.01 $6.07 $5.78 $5.90 281 800
Aug 05, 2016 $5.92 $6.05 $5.88 $5.99 531 000
Aug 04, 2016 $5.91 $5.98 $5.84 $5.90 324 700
Aug 03, 2016 $5.66 $5.99 $5.66 $5.89 435 400
Aug 02, 2016 $5.85 $5.94 $5.64 $5.74 382 900
Aug 01, 2016 $5.97 $6.09 $5.79 $5.86 581 000
Jul 29, 2016 $6.00 $6.02 $5.89 $5.96 271 800
Jul 28, 2016 $6.02 $6.12 $5.90 $5.98 328 500
Jul 27, 2016 $5.76 $6.04 $5.76 $6.01 451 900
Jul 26, 2016 $5.64 $5.83 $5.54 $5.75 312 500
Jul 25, 2016 $5.65 $5.69 $5.50 $5.65 235 200
Jul 22, 2016 $5.58 $5.75 $5.52 $5.65 193 200
Jul 21, 2016 $5.74 $5.85 $5.48 $5.58 465 900
Jul 20, 2016 $5.61 $5.80 $5.61 $5.73 417 400
Jul 19, 2016 $5.88 $5.94 $5.58 $5.60 231 200
Jul 18, 2016 $5.80 $5.90 $5.74 $5.89 288 900
Jul 15, 2016 $5.58 $5.87 $5.54 $5.81 350 700
Jul 14, 2016 $5.65 $5.71 $5.52 $5.54 235 500
Jul 13, 2016 $5.86 $5.92 $5.60 $5.60 304 800
Jul 12, 2016 $5.81 $5.98 $5.78 $5.85 336 800
Jul 11, 2016 $5.76 $5.88 $5.68 $5.77 359 100
Jul 08, 2016 $5.60 $5.74 $5.56 $5.73 431 600
Jul 07, 2016 $5.49 $5.60 $5.40 $5.56 271 000
Jul 06, 2016 $5.36 $5.62 $5.34 $5.48 325 100
Jul 05, 2016 $5.43 $5.49 $5.33 $5.37 235 100
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT